Myocardial Remodeling in Hypertension: Toward a New View of Hypertensive Heart Disease

被引：127

作者：

Gonzalez, Arantxa ^{[1
,2
,3
]}

Ravassa, Susana ^{[1
,2
,3
]}

Lopez, Begona ^{[1
,2
,3
]}

Moreno, Maria U. ^{[1
,2
,3
]}

Beaumont, Javier ^{[1
,2
,3
]}

San Jose, Gorka ^{[1
,2
,3
]}

Querejeta, Ramon ^{[4
]}

Bayes-Genis, Antoni ^{[3
,5
,6
,7
]}

Diez, Javier ^{[1
,2
,3
,8
,9
]}

机构：

[1] Univ Navarra, Ctr Appl Med Res, Program Cardiovasc Dis, Ave Pio 12,55, Pamplona 31008, Spain

[2] Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain

[3] Carlos III Inst Hlth, CIBERCV, Madrid, Spain

[4] Univ Basque Country, Donostia Univ Hosp, Div Cardiol, San Sebastian, Spain

[5] Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain

[6] Hosp Badalona Germans Trias & Pujol, Cardiol Serv, Badalona, Spain

[7] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain

[8] Univ Navarra, Univ Navarra Clin, Dept Cardiol & Cardiac Surg, Pamplona, Spain

[9] Univ Navarra, Univ Navarra Clin, Dept Nephrol, Pamplona, Spain

来源：

HYPERTENSION | 2018年 / 72卷 / 03期

关键词：

LEFT-VENTRICULAR HYPERTROPHY; REGULATORY T-CELLS; PRESERVED EJECTION FRACTION; PATHOLOGICAL CARDIAC-HYPERTROPHY; CORONARY FLOW RESERVE; C-REACTIVE PROTEIN; DIASTOLIC DYSFUNCTION; ARTERIAL-HYPERTENSION; GENE-EXPRESSION; BLOOD-PRESSURE;

D O I：

10.1161/HYPERTENSIONAHA.118.11125

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

[No abstract available]

引用

页码：549 / 558

页数：10

共 104 条

[1] The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart
Altara, Raffaele
Mallat, Ziad
Booz, George W.
Zouein, Fouad A.
[J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
[2] Coronary reserve impairment prevents the improvement of left ventricular dysfunction and adversely affects the long-term outcome of patients with hypertensive dilated cardiomyopathy
Angelim Pereira, Valeria Fontenelle
Frimm, Clovis de Carvalho
Tudi Rodrigues, Ana Clara
Statistician, Mariana Curi
[J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2010, 4 (01) : 14 - 21
[3] Discovering cardiac pericyte biology: From physiopathological mechanisms to potential therapeutic applications in ischemic heart disease
Avolio, Elisa
Madeddu, Paolo
[J]. VASCULAR PHARMACOLOGY, 2016, 86 : 53 - 63
[4] Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review
Bang, Casper N.
Devereux, Richard B.
Okin, Peter M.
[J]. JOURNAL OF ELECTROCARDIOLOGY, 2014, 47 (05) : 630 - 635
[5] Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension
Bautista, LE
Vera, LM
Arenas, IA
Gamarra, G
[J]. JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (02) : 149 - 154
[6] Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease
Behr, TM
Willette, RN
Coatney, RW
Berova, M
Angermann, CE
Anderson, K
Sackner-Bernstein, JD
Barone, FC
[J]. JOURNAL OF HYPERTENSION, 2004, 22 (03) : 583 - 592
[7] ECM remodeling in hypertensive heart disease
Berk, Bradford C.
Fujiwara, Keigi
Lehoux, Stephanie
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) : 568 - 575
[8] Blood pressure, C-reactive protein, and risk of future cardiovascular events
Blake, GJ
Rifai, N
Buring, JE
Ridker, PM
[J]. CIRCULATION, 2003, 108 (24) : 2993 - 2999
[9] Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
Brilla, CG
Funck, RC
Rupp, H
[J]. CIRCULATION, 2000, 102 (12) : 1388 - 1393
[10] IMPAIRED DIASTOLIC FUNCTION AND CORONARY RESERVE IN GENETIC-HYPERTENSION - ROLE OF INTERSTITIAL FIBROSIS AND MEDIAL THICKENING OF INTRAMYOCARDIAL CORONARY-ARTERIES
BRILLA, CG
JANICKI, JS
WEBER, KT
[J]. CIRCULATION RESEARCH, 1991, 69 (01) : 107 - 115

← 1 2 3 4 5 6 7 8 9 10 →